Recent advances in the use of genetically engineered negative signaling molecules to treat allergic diseases.

Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt für Sera und Impfstoffe) zu Frankfurt a.M

Volumn , Issue 95, 2006, Pages

  Saxon, Andrew ^a   Zhu, Daocheng ^a   Zhang, K ^a   Chan, Lisa A ^a   Kepley, Christopher L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; HYBRID PROTEIN; IMMUNOGLOBULIN E RECEPTOR;

ARTICLE; B LYMPHOCYTE; BASOPHIL; DENDRITIC CELL; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; MAST CELL; PHYSIOLOGY; SIGNAL TRANSDUCTION;

B-LYMPHOCYTES; BASOPHILS; DENDRITIC CELLS; HUMANS; HYPERSENSITIVITY; MAST CELLS; RECEPTORS, IGE; RECEPTORS, IGG; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

EID: 34247125700     PISSN: 09368671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)